- Home
- ANDE vs OCUL Comparison
ANDE vs OCUL Comparison
Compare ANDE & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANDE | OCUL |
|---|---|---|
| Founded | 1947 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ANDE | OCUL |
|---|---|---|
| Price | $63.95 | $10.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $75.00 | $22.90 |
| AVG Volume (30 Days) | 262.9K | ★ 7.8M |
| Earning Date | 05-20-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.26% | N/A |
| EPS Growth | ★ 12.93 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $11,008,928,000.00 | $1,990,000.00 |
| Revenue This Year | $13.28 | $9.35 |
| Revenue Next Year | $5.76 | $92.88 |
| P/E Ratio | $77.63 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $31.03 | $6.23 |
| 52 Week High | $70.06 | $16.44 |
Technical Indicators
Market Signals| Indicator | ANDE | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 49.43 | 54.34 |
| Support Level | $62.90 | $6.55 |
| Resistance Level | $70.06 | $12.63 |
| Average True Range (ATR) | 2.26 | 0.79 |
| MACD | -0.59 | 0.34 |
| Stochastic Oscillator | 28.93 | 76.00 |
Price Performance
Historical ComparisonAbout ANDE Andersons Inc. (The)
Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.